The current financial score of DR Horton Inc is 8.18. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 9.23B, representing a year-over-year increase of 0.02%, while its net profit experienced a year-over-year increase of 11.68%.
The current valuation score of DR Horton Inc is 8.34. Its current P/E ratio is 13.01, which is 20.13% below the recent high of 15.63 and 57.26% above the recent low of 5.56.
The current earnings forecast score of DR Horton Inc is 6.67. The average price target is 157.75, with a high of 206.00 and a low of 101.00.
The current price momentum score of DR Horton Inc is 3.02. Currently, the stock price is trading between the resistance level at 144.45 and the support level at 131.95, making it suitable for range-bound swing trading.
The current institutional shareholding score of DR Horton Inc is 7.00. The latest institutional shareholding proportion is 89.64%, representing a quarter-over-quarter decrease of 2.00%. The largest institutional shareholder is Bill Smead, holding a total of 1.40M shares, representing 4.06% of shares outstanding, with 9.27% decrease in holdings.
The current risk assessment score of DR Horton Inc is 7.74. The company's beta value is 1.43. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.